User menu

Evaluation of a new commercial Clostridium difficile toxin A enzyme immunoassay using diarrhoeal stools.

Bibliographic reference Delmée, Michel ; Mackey, T ; Hamitou, A. Evaluation of a new commercial Clostridium difficile toxin A enzyme immunoassay using diarrhoeal stools.. In: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, Vol. 11, no. 3, p. 246-9 (1992)
Permanent URL
  1. BARTLETT JOHN, Introduction, Clostridium Difficile (1988) ISBN:9780125934107 p.1-13, 10.1016/b978-0-12-593410-7.50005-3
  2. Lyerly D M, Krivan H C, Wilkins T D, Clostridium difficile: its disease and toxins., 10.1128/cmr.1.1.1
  3. George WL, Sutter VL, Citron D, Finegold S: Selective and differential medium for isolation ofClostridium difficile. Journal of Clinical Microbiology 1979, 9: 214–219.
  4. Delmée M, Vandercam B, Avesani V, Michaux JL: Epidemiology and prevention ofClostridium difficile infections in a leukemia unit. European Journal of Clinical Microbiology 1987, 6: 623–627.
  5. Allen SD, Baron EJ:Clostridium. In: Balows A, Hausler WJ, Herrmann KL, Isenberg HD, Shadomy HJ (ed): Manual of clinical microbiology, 5th edition. American Society for Microbiology, Washington, DC, 1991, p. 505–521.
  6. Laughon B. E., Viscidi R. P., Gdovin S. L., Yolken R. H., Bartlett J. G., Enzyme Immunoassays for Detection of Clostridium difficile Toxins A and B in Fecal Specimens, 10.1093/infdis/149.5.781
  7. Aronsson B, Granström M, Möllby R, Nord CE: Enzyme immunoassay for detection ofClostridium difficile toxins A and B in patients with antibiotic-associated diarrhoea and colitis. European Journal of Clinical Microbiology 1985, 4: 102–107.
  8. Walker RC, Ruane PJ, Rosenblatt JE, Lyerly DM, Gleaves CA, Smith TF, Pierce PF, Wilkins TD: Comparison of culture, cytotoxicity assays, and enzymelinked immunosorbent assay for toxin A and toxin B in the diagnosis ofClostridium difficile enteric disease. Diagnostic Microbiology and Infectious Disease 1986, 5: 61–69.
  9. Lyerly DM, Wilkins TD: Commercial latex test forClostridium difficile toxin A does not detect toxin A. Journal of Clinical Microbiology 1986, 23: 622–623.
  10. Borriello SP, Barclay FE, Reed PJ, Welch AR, Brown JD, Burdon DW: Analysis of latex agglutination test forClostridium difficile toxin A (D-1) and differentiation betweenClostridium difficile toxins A and B and latex reactive protein. Journal of Clinical Pathology 1987, 40: 573–580.
  11. McFarland LV, Elmer GW, Stamm WE, Mulligan ME: Correlation of immunoblot type, enterotoxin production, and cytotoxin production with clinical manifestations ofClostridium difficile infection in a cohort of hospitalized patients. Infection and Immunity 1991, 59: 2456–2462.
  12. Borriello SP, Ketley JM, Mitchell TJ, Barclay FE, Welch AR, Price AB, Stephen J:Clostridium difficile — a spectrum of virulence and analysis of putative virulence determinants in the hamster model of antibiotic-associated colitis. Journal of Medical Microbiology 1987, 24: 53–64.
  13. Delmée M, Avesani V: Virulence of ten serogroups ofClostridium difficile in hamsters. Journal of Medical Microbiology 1990, 33: 85–90.